Cartilage is a highly specialized tissue with an important function: bearing compressive load in joints. Since cartilage has limited repair capacity, its destruction results in major problems in joint diseases such as rheumatoid arthritis and osteoarthrosis. Cartilage also serves as the precursor for most bone tissues during development. Therefore, the study of cartilage formation is important for elucidation of the mechanisms of skeletal development and joint diseases. Cartilage has at least three characteristics. First, it has no blood vessels or innervation. Without blood vessels, this tissue cannot be a primary region of inflammation. Secondly, it consists of a single cell type, chondrocyte, which undergoes various stages in differentiation. Because of a single cell type, the concept of parenchyma or intima does not hold true to cartilage tissue. Thirdly, it consists of unique extracellular matrix molecules. For example, type II, IX, X, and XI collagens are unique to cartilage. They form collagen fibrils and fibers that endow cartilage with tensile strength. Cartilage also contains a variety of proteo glycans such as aggrecan, decorin, biglycan, PG-Lb, and fibromodulin. Among them, aggrecan and PG-Lb are rather unique to cartilage. Aggrecan is one of the major compo nents of cartilage, and binds to hyaluronan (HA) and link protein to form huge aggregates. These aggregates lead to a hydrated gel-like structure of cartilage and resistibility to compression and deformation in joints. In this review, we describe structures and function of aggrecan, and its genetic disorders. 1 To whom correspondence should be addressed. Tel: +1-301-402-0512, Fax: +1-301-402-0897,E-mail:
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Molecular and gene structure Proteoglycan is defined as a molecule composed of a protein (core protein) and glycosaminoglycan chains that covalently attached to the core protein (1) . The core protein of aggrecan has a molecular mass of ?230 kDa. With many glycosaminoglycan chains (up to ?130 chains) attached to the core protein, the total molecular mass can reach ? 2,200 kDa. Complete coding sequences for aggrecan have been determined for the rat (2), mouse (3), human (4), and chicken (5) . The core protein consists of three globular domains, G1, G2, and G3, and two glycosaminoglycanattachment domains, KS and CS domains, located between the G2 and G3 domains. Between G1 and G2, there is another rod-shaped domain called the interglobular domain (IGD). Similar domain structures are also found in other proteoglycans such as PG-M/versican (6, 7), neurocan (8), and brevican (9) (Fig. 1) . Therefore, these extracellular matrix proteoglycans, sharing similar domain structures, form a gene family (10). The coding sequence of the three globular domains shows high homology among species, while that of the KS and CS attachment domains is relatively diverse. Aggrecan core protein is encoded by a single gene that is mapped to chromosome 7 in mouse (11) and chromosome 15 in humans (12). The genomic structure of rat, chicken, mouse, and human aggrecan has been reported, showing a high similarity among species (13-16). The aggrecan gene contains 18 exons: Exon 1 is untranslated and exon 2 contains a translation initiation codon. The organization of exons is strongly correlated to the specific domains, as shown in Fig. 1 . Comparison of the exon organization among species reveals that the aggrecan gene family is evolved distinctly from the link protein gene, which encodes a globular structure similar to the G1 domain. G1 
Keratan sulfattt (KS) domain
The keratan sulfate (KS) domain is located at the Cterminus of the G2 domain, and is encoded by exon 11. This domain varies in amino acid sequences among species. The possible consensus sequence for attachment of KS in human is E-(E,K)-P-F-P-S or E-E-P-(S,F)-P-S (4, 31). These sequences are not found in mice and rats. Rodents do not have keratan sulfate chains in their aggrecan. This may be due to the absence of these sequences.
Chondroitin sulfate (CS) domain The chondroitin sulfate (CS) domain is the largest domain of aggrecan, attached by approximately a hundred chains of chondroitin sulfate. This domain is encoded by a single large exon, exon 12, with a size of -3.5 kb. The CS domain consists of approximately 120 serine-glycine (S-G) repeats. The possible recognition sequence for the attach ment of CS chains have been proposed to be S-G-X-G (32) or (D,E)-X-S-G (33). In addition to the primary sequence, molecular chaperon surveillance mechanisms and localiza tion of enzymes for post-translational modifications may also be necessary for the recognition. Recent recombinant study has revealed that a truncated CS-G3 segment of aggrecan is substituted with CS. On the other hand, that of G1-CS is not (34). The S-G pairs occur in two distinct pattern of repeating sequences designated the CS-1 and CS-2 repeat regions. Human cDNA contains a sub region of the CS-1 repeat that was remarkably conserved in repeats of 19 amino acids. Recently, the presence of variable number of tandem repeats (VNTR) in human aggrecan CS domain was identified, ranging from 13 to 33 (35). This variation may affect the CS content. Each repeat contains two possible attachment sites for CS, so that the range of VNTR may vary as many as 40 CS chains per core protein monomer. Assuming full substitutions, there would be a range of 172 to 132 CS chains between these two alleles, respectively, representing a 30% variation. Since CS chains contribute to a hydrated gel-like structure unique to cartilage, such VNTR may influence cartilage function and may explain the fragility of some diseases such as juvenile onset of osteoarthrosis.
A highly sensitive fluorotag HPLC method to quantitate products in chondroitinase digests of human aggrecan isolated from cartilages of individuals at various ages indicated age-related changes in the structure of CS chains (36). A decrease in the average chain size occurred between fetal and early postnatal ages. At skeletal maturity, the average aggrecan CS chain size decreases from 20 kDa to approximately 8 kDa, and the ratio of 6-to 4-sulfation on interior disaccharide is increased from ?0.77 to ?23 in the adult, as shown in Fig. 2 . These age-related changes in CS chain of aggrecan molecule may affect not only its hydrated size but also the interactions with other cartilage molecules, which are important for cartilage functions.
G3 domain
The G3 domain, located at the C-terminus, consists of three modules: epidermal growth factor (EGF)-like mod ule, C-type lectin-like module, and complement regulatory proteins (CRP)-module (2). The structure of the G3 domain is also found in other extracellular matrix molecules and proteoglycans such as PG-M/versican, neurocan, and brevican. PG-M/versican and neurocan have two EGF-like modules. Similarly, aggrecan has two EGF-like modules, EGF-1 (37) and EGF-2 (38). However, their expression varies among species (39). For example, both modules are found in human, but bovine EGF1 expresses very little. In mouse, rat, and dog, EGF1 is a part of intron and is not translated.
The lectin module of aggrecan binds to fucose and galactose (40). The recombinant C-terminal region (EGFlike module, C-type lectin module, and CRP-module) of PG-M/versican has the activity to bind to heparin and heparan sulfate as well as to these simple carbohydrates (41). The lectin module of PG-M/versican binds to tenas cin-R by carbohydrate-protein interactions (42). Com parison of interactions with tenascin-R among a family of the G3 domain-containing proteoglycans revealed not only a carbohydrate-protein interaction but also a distinct pro tein-protein interaction (43). Aggrecan G3 domain may interact with tenascin in the cartilage. However, in situ hybridization data indicates that mRNAs of both genes are expressed in a mutually exclusive manner (44) .
With aging, the population of aggrecan without the G3 domain increases compared to that with full length (36, 45) . This is probably due to proteolytic cleavage in the cartilage matrix rather than alternative splicing or other intracellular modification.
Interglobular domain (IGD)
The interglobular domain (IGD) between the G1 and G2 domains has a rod-shape, and contains proteolytic cleavage sites susceptible to a variety of proteinases. For example, matrix metalloproteinases (MMPs) such as MMP-1, 2, 3, and 8, serine proteinases such as plasmin and leukocyte elastase, and acid proteinases like cathepsin B cleave their specific sites in IGD (46) . Since cleavage of IGD can be related to the turnover of aggrecan, identification of the enzyme(s), which are involved in degradation of aggrecan in vivo, is important. Studies on the aggrecan fragments extracted from joint cartilage or synovial fluid suggested the presence of a proteinase that cleaves a specific site in IGD, which was named "aggrecanase" (47) . In the articular cartilage of normal adults, at least eleven aggrecan frag ments have been found with the molecular weight ranging from 300,000 to 43,000 and degradation seems to start at the C-terminus (48) . Aggrecanase has been implicated in joint destructive diseases such as osteoarthrosis (OA) (47, 49) . The pathogenesis of OA is presently focused on proteolytic degradation of cartilaginous molecules. Based on the size variation of aggrecan fragments extracted from articular cartilage and synovial fluid of OA patients, ag grecanase seems to cleave not only the specific site in the IGD but also four similar sites in the CS domain, which are well conserved among species. As well as articular carti lage, meniscus and ligaments may also serve as source of aggrecan fragments (50) . Interestingly, the Gl domain of aggrecan is more abundant in these tissues. Animal models of aggrecan gene defects Two autosomal recessive chondrodysplasias, cartilage matrix deficiency (cmd) in mice and nanomelia in chicken were shown to be caused by mutations in the aggrecan gene. The cartilage matrix deficiency (cmd/cmd) is the first example of the mutation of a proteoglycan gene identified in mammals. The homozygotes (cmd/cmd) are characterized by dwarfism, short snout, and cleft palate (54) . Heterozy gous mice (cmd/+) are born normal, while homozygous mice (cmd/cmd) die just after birth due to respiratory failure. The cartilage of homozygous mice appears as tightly packed chondrocytes with little matrix, unlike the extensive matrix seen in normal mice. The cmd aggrecan gene has a single 7 by deletion in exon 5 which encodes the B loop of the G1 domain. This deletion causes a frameshift resulting in the appearance of a termination codon in exon 6 (11). The potentially truncated 32 kDa polypeptide created by this mutation contains an incomplete PTR structure incapable of HA-binding. Biochemical and im munological studies have demonstrated the absence of aggrecan in the cartilage matrix of cmd mice, although normal levels of link protein and type II collagen were detected (55) . Cmd heterozygotes (56) are apparently normal at birth. Since heterozygous cmd mice have only one normal allele of the aggrecan gene, some metabolic differences in aggrecan of the heterozygotes may occur and create abnormal phenotypic changes after birth. Quantitative reverse transcriptase (RT)-PCR studies revealed reduced levels of aggrecan mRNA in cmd heterozygotes and in homozygotes to 81 and 41%, respectively, compared to that in the wild type mice. Those of type II collagen mRNA of both the heterozygote and of the homozygote were similar to that in the wild type mice. The levels of chon droitin sulfate in cartilage from 90-day-old cmd hetero zygous mice was reduced to 87% of the wild type. Since aggrecan is important in cartilage development, the re duced level of aggrecan is likely to affect the growth of the heterozygotes. Indeed, cmd heterozygotes show two abnor mal phenotypes; a slight dwarfism and late onset spinal misalignment.
Approximately 28 days after birth, the heterozygotes are noticeably smaller than the wild type mice. The dwarfism of the heterozygotes is proportional. The most notable abnormality of the cmd heterozygotes is a misalignment of the cervical and thoracic spine which develops about one year after birth (Fig. 3) . In mice, the cervical spine is particularly susceptible to gravitational loading because the animals have to support their head. The heterozygotes die after 12-15 months, while the wild type mice live for 2-2.5 years. They develop a marked lordosis of the cervical spine and kyphosis of the thoraco-lumbar spine. Mice with spinal distortions suddenly acquire a spastic gait disturbance and showed decreased movement. They were unable to eat and starved to death within one month following acquisition of the gait disturbance. From histological examinations, the heterozygotes showed her niation of the vertebral disc, deformation of the vertebral bodies and degenerative changes of the cervico-thoracic spine. Compression of the spinal cord by the herniated disc was also observed in these mice, explaining their spastic gait. Disappearance of the apophysis of the vertebral bodies was also observed. In contrast, such specific changes are hardly found in the spine from one-year old wild type mice. Alcian blue and toluidin blue stainings in the heterozygotes show a reduction of glycosaminoglycans.
Alcian blue stained tissues surrounding the chondrocytes in the disc cartilage of the heterozygotes, while diffuse staining was observed in the wild type. General features of spinal degeneration are accompanied by pathological changes in both the intervertebral discs and the facet joints. In the cmd heterozygotes, pathological changes were found entirely in the intervertebral discs, while the facet joints were appar ently normal.
These histological findings indicate that the primary lesion lies in the disc and that degeneration characteristic of reactive bone growth did not occur. The knee joint and other cartilaginous tissues were apparently normal in the het- erozygotes. The turnover of collagen within the disc is estimated to be very slow (> 100 years), while the aggrecan turnover is more rapid, with the half-life of 8-300 days in rabbits (57) . Because of the relatively rapid turnover of aggrecan, decreased synthesis of aggrecan is likely to cause significant reduction of its deposition in the tissue. A certain level of aggrecan deposition in the disc may be critical for maintenance of disc function. For instance, aggrecan has been shown to play a key role in maintaining the collagen network. Electron microscopy of the cartilage of the cmd homozygotes shows abnormal collagen fibrils which display an increase in the diameter, the appearance of periodic banding patterns, and bundling formation (58) . These results also suggest a role of aggrecan in collagen fibrillogenesis. Similar changes, such as rough fiber distri bution with concentric patterns, are found in the disc of the cmd heterozygotes likely due to a reduced deposition of aggrecan in the disc. Chondrocytes in the affected cervical spine of the heterozygotes are abnormally packed together, containing degenerative vacuoles in their cytoplasm, and rough fibers in the matrix are organized in concentric circles which surrounded the chondrocytes. Control chondrocytes in the wild type mice are distributed as individual cells in a fine extracellular matrix. It is interesting to note that the pathological changes in the tissues of the cmd heterozygotes were found mainly in the specific portions of the spine which are most susceptible to gravitational load.
Cmd has been classified as an autosomal recessive disorder. Autosomal recessive inheritance is defined as inheritance in which a clinical phenotype occurs only when both alleles are defective. However, heterozygotes of some recessive disorders may have subtle differences in pheno type which may be accentuated by environmental factors. The pathologies reported here for cmd heterozygote mice suggest that defects in one of alleles of this gene can have clinical manifestations. Although several genetic disorders of collagens, such as osteogenesis imperfecta and chon drodysplasia (59-61) have been reported, human genetic diseases caused by a defect of the aggrecan gene have not yet been identified. The cmd heterozygous mice show a high incidence of spinal misalignment and movement problems which develop with age, primarily involving spastic paraly sis of the hind limbs. This resembles spinal paralysis in humans. It is conceivable that an analogous aggrecan gene defect causes spinal disc herniation or spondylo-myelo pathy, which are well known as diseases typical of older humans. The phenotype of the heterozygous cmd mice may provide a useful clue for linkage studies of aggrecan gene defects in suspected human patients. Our findings support aggrecan as a candidate gene predisposing individuals to spinal problems. The other aggrecan gene defect is nano melia in chicken, which bears a phenotype similar to the cmd mouse. A point mutation in the aggrecan gene was found at the end of exon 12 encoding CS domain in the aggrecan gene of chick nanomelia (5) . In nanomelia, a truncated protein is localized in the endoplasmic reticulum (62) , suggesting that G3 is important for intracellular trafficking.
Conclusions
Aggrecan is one of the major structural macromolecules of cartilage. Studies on the structure and function of aggrecan may lead to prophylaxis and treatment of joint destructive diseases such as osteoarthrosis. Since cartilage serves as a precursor tissue of bone formation, aggrecan plays a critical role in skeletal formation. Studies on animal models of aggrecan gene defects such as cmd and nanomelia will provide us with clues to identification of human genetic diseases caused by aggrecan gene defects.
